Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2013-12-01 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75020), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ALEXANDRE DUMAS : revenue, balance sheet and financial ratios
PHARMACIE ALEXANDRE DUMAS is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75020),
this company of category PME
shows in 2017 a revenue of 3.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ALEXANDRE DUMAS (SIREN 798327318)
Indicator
2021
2017
Revenue
N/C
3 282 947 €
Net income
167 937 €
55 229 €
EBITDA
N/C
222 731 €
Net margin
N/C
1.7%
Revenue and income statement
In 2021, PHARMACIE ALEXANDRE DUMAS generates positive net income of 168 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2021: 55 k€ -> 168 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
167 937 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 158%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
157.946%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
27.303%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2021
Debt ratio
661.924
157.946
Financial autonomy
8.854
27.303
Repayment capacity
31.852
None
Cash flow / Revenue
1.505%
None%
Sector positioning
Debt ratio
157.952021
2017
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Average-10 pts over 2 years
In 2021, the debt ratio of PHARMACIE ALEXANDRE DUMAS (157.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
27.3%2021
2017
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Average
In 2021, the financial autonomy of PHARMACIE ALEXANDRE DUMAS (27.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
31.85 years2017
2017
Q1: 2.26 years
Med: 5.88 years
Q3: 10.41 years
Watch
In 2017, the repayment capacity of PHARMACIE ALEXANDRE DUMAS (31.85) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 78.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2021
Liquidity ratio
89.799
78.292
Interest coverage
17.051
None
Sector positioning
Liquidity ratio
78.292021
2017
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Watch
In 2021, the liquidity ratio of PHARMACIE ALEXANDRE DUMAS (78.29) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
17.05x2017
2017
Q1: 2.81x
Med: 8.18x
Q3: 15.34x
Excellent
In 2017, the interest coverage of PHARMACIE ALEXANDRE DUMAS (17.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 170 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1393 days. Excellent situation: suppliers finance 1223 days of the operating cycle (retail model).
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
170 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1393 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ALEXANDRE DUMAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2021
Operating WCR
337 651 €
0 €
Inventory turnover (days)
33
0
Customer payment term (days)
2
170
Supplier payment term (days)
101
1393
Positioning of PHARMACIE ALEXANDRE DUMAS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE ALEXANDRE DUMAS is estimated at
1 926 307 €
(range 1 238 625€ - 2 975 539€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
1238k€1926k€2975k€
1 926 307 €Range: 1 238 625€ - 2 975 539€
NAF 5 année 2021
Valuation method used
Net Income Multiple
167 937 €
×
11.5x
=1 926 307 €
Range: 1 238 625€ - 2 975 539€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ALEXANDRE DUMAS with other companies in the same sector:
Frequently asked questions about PHARMACIE ALEXANDRE DUMAS
What is the revenue of PHARMACIE ALEXANDRE DUMAS ?
The revenue of PHARMACIE ALEXANDRE DUMAS in 2017 is 3.3 M€.
Is PHARMACIE ALEXANDRE DUMAS profitable?
Yes, PHARMACIE ALEXANDRE DUMAS generated a net profit of 168 k€ in 2021.
Where is the headquarters of PHARMACIE ALEXANDRE DUMAS ?
The headquarters of PHARMACIE ALEXANDRE DUMAS is located in PARIS (75020), in the department Paris.
Where to find the tax return of PHARMACIE ALEXANDRE DUMAS ?
The tax return of PHARMACIE ALEXANDRE DUMAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ALEXANDRE DUMAS operate?
PHARMACIE ALEXANDRE DUMAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart